Get started
CHINA RES.PHARMA.GRP O.N.CHINA RES.PHARMA.GRP O.N.CHINA RES.PHARMA.GRP O.N.

CHINA RES.PHARMA.GRP O.N.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

640 chart

Upcoming earnings

Next report date
Report period
H1 2024
EPS estimate
0.06EUR
Revenue estimate
‪17.04 B‬EUR

Key stats

Market capitalization
‪3.71 B‬EUR
Dividend yield (indicated)
3.42%
Price to earnings Ratio (TTM)
7.940
Basic EPS (TTM)
0.070EUR
Net income (FY)
‪494.02 M‬EUR
Revenue (FY)
‪31.37 B‬EUR
Shares float
‪1.69 B‬
Beta (1Y)
0.87

About CHINA RESOURCES PHARMACEUTICAL GR

Sector
Health Technology
CEO
Xiao Song Bai
Headquarters
Hong Kong
Website
crpharm.com
Employees (FY)
‪72.99 K‬
Founded
1938
ISIN
HK0000311099
FIGI
BBG00F3ZDBK4
China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. It operates through the following segments: Manufacturing, Distribution, Retail, and Others. The Manufacturing segment handles the research and development, manufacture, and sale of pharmaceutical and healthcare products. The Distribution segment focuses on the distribution, warehousing, logistics, and pharmaceutical supply chain solutions and services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. The Retail segment deals with the operation of retailing of pharmacy stores. The Others segment comprises of property holding. The company was founded in 1938 and is headquartered in Hong Kong.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 640 is 0.595 EUR — it has increased by 2.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHINA RES.PHARMA.GRP O.N. stocks are traded under the ticker 640.
CHINA RES.PHARMA.GRP O.N. is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
640 stock is 2.52% volatile and has beta coefficient of 0.87. Check out the list of the most volatile stocks — is CHINA RES.PHARMA.GRP O.N. there?
640 earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.03 EUR resulting in a 100.43% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about CHINA RES.PHARMA.GRP O.N. earnings.
CHINA RES.PHARMA.GRP O.N. revenue for the last quarter amounts to ‪16.33 B‬ EUR despite the estimated figure of ‪15.93 B‬ EUR. In the next quarter revenue is expected to reach ‪16.11 B‬ EUR.
Yes, you can track CHINA RES.PHARMA.GRP O.N. financials in yearly and quarterly reports right on TradingView.
640 stock has risen by 5.31% compared to the previous week, the last month showed zero change in price, over the last year CHINA RES.PHARMA.GRP O.N. has showed a 31.21% decrease.
640 net income for the last quarter is ‪94.67 M‬ EUR, while the quarter before that showed ‪355.32 M‬ EUR of net income which accounts for −73.36% change. Track more CHINA RES.PHARMA.GRP O.N. financial stats to get the full picture.
Today CHINA RES.PHARMA.GRP O.N. has the market capitalization of ‪3.71 B‬, it has increased by 3.71% over the last week.
Yes, 640 dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 3.23%. Tracking CHINA RES.PHARMA.GRP O.N. dividends might help you take more informed decisions.
CHINA RES.PHARMA.GRP O.N. dividend yield was 3.31% in 2023, and payout ratio reached 25.03%. The year before the numbers were 2.53% and 24.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 640 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA RES.PHARMA.GRP O.N. stock right from TradingView charts — choose your broker and connect to your account.
640 reached its all-time high on Sep 3, 2018 with the price of 1.400 EUR, and its all-time low was 0.345 EUR and was reached on Dec 20, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪72.99 K‬ employees. See our rating of the largest employees — is CHINA RES.PHARMA.GRP O.N. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA RES.PHARMA.GRP O.N. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA RES.PHARMA.GRP O.N. stock shows the sell signal. See more of CHINA RES.PHARMA.GRP O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CHINA RES.PHARMA.GRP O.N. future price: according to them, 640 price has a max estimate of 1.11 EUR and a min estimate of 0.59 EUR. Read a more detailed CHINA RES.PHARMA.GRP O.N. forecast: see what analysts think of CHINA RES.PHARMA.GRP O.N. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA RES.PHARMA.GRP O.N. EBITDA is ‪1.59 B‬ EUR, and current EBITDA margin is 5.70%. See more stats in CHINA RES.PHARMA.GRP O.N. financial statements.